Total Payments
$150,758
2024 Payments
$7,808
Companies
33
Transactions
1,499
Medicare Patients
18,100
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$50,041 (33.2%)
Other$37,750 (25.0%)
Consulting$37,050 (24.6%)
Travel$17,075 (11.3%)
Research$8,657 (5.7%)
Education$185.44 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $50,041 | 1,428 | 33.2% |
| Consulting Fee | $37,050 | 21 | 24.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,750 | 14 | 23.7% |
| Travel and Lodging | $17,075 | 28 | 11.3% |
| Unspecified | $8,657 | 1 | 5.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,000 | 1 | 1.3% |
| Education | $185.44 | 6 | 0.1% |
Payments by Type
General
$142,101
1,498 transactions
Research
$8,657
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ATRICURE, INC. | $64,365 | 110 | $0 (2024) |
| Abbott Laboratories | $31,551 | 587 | $0 (2024) |
| PFIZER INC. | $18,737 | 135 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $13,741 | 180 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $10,075 | 100 | $0 (2024) |
| Biosense Webster, Inc. | $5,803 | 199 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $2,644 | 42 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $843.06 | 41 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $722.37 | 45 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $498.74 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,808 | 215 | Abbott Laboratories ($4,153) |
| 2023 | $10,653 | 209 | Abbott Laboratories ($6,571) |
| 2022 | $31,079 | 261 | AtriCure, Inc. ($23,450) |
| 2021 | $28,689 | 198 | ATRICURE, INC. ($19,973) |
| 2020 | $15,912 | 120 | ATRICURE, INC. ($7,798) |
| 2019 | $18,964 | 192 | AtriCure, Inc. ($11,594) |
| 2018 | $14,855 | 168 | PFIZER INC. ($8,547) |
| 2017 | $22,799 | 136 | Janssen Pharmaceuticals, Inc ($11,240) |
All Payment Transactions
1,499 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $46.81 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $29.72 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $36.55 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Abbott Laboratories | ENSITE PRECISION (Device) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Electrophysiology | ||||||
| 12/12/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/12/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/11/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $39.49 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: DEVICES | ||||||
| 12/09/2024 | Biosense Webster, Inc. | NUVISION ICE CATHETER (Device), QDOT MICRO Catheter | Food and Beverage | In-kind items and services | $148.37 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $72.26 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/06/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/19/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $109.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $50.65 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $99.03 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/08/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/08/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $37.71 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/01/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $37.41 | General |
| Category: Cardiac Rhythm Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTEN ATRIAL FIBRILLATION | AtriCure, Inc. | $8,657 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 4,353 | 7,655 | $1.8M | $446,278 |
| 2022 | 39 | 4,537 | 7,961 | $1.8M | $467,105 |
| 2021 | 42 | 4,802 | 8,226 | $2.0M | $551,233 |
| 2020 | 42 | 4,408 | 7,925 | $2.2M | $531,470 |
Total Patients
18,100
Total Services
31,767
Medicare Billing
$2.0M
Procedure Codes
160
All Medicare Procedures & Services
160 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 830 | 1,099 | $226,466 | $101,902 | 45.0% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 65 | 66 | $216,414 | $49,001 | 22.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 523 | 1,548 | $151,704 | $27,226 | 17.9% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 41 | 41 | $103,279 | $24,994 | 24.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 357 | 1,051 | $111,406 | $22,885 | 20.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 284 | 379 | $70,996 | $22,558 | 31.8% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 56 | 56 | $95,144 | $20,907 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 120 | 136 | $37,808 | $18,372 | 48.6% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 53 | 66 | $81,114 | $15,889 | 19.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 912 | 1,361 | $81,660 | $14,986 | 18.4% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 20 | 20 | $58,860 | $14,443 | 24.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 181 | 513 | $106,191 | $13,839 | 13.0% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 20 | 20 | $49,140 | $13,121 | 26.7% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 36 | 39 | $47,970 | $9,389 | 19.6% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 25 | 25 | $37,175 | $9,065 | 24.4% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 80 | 109 | $31,174 | $8,997 | 28.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 34 | 197 | $28,368 | $5,533 | 19.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 72 | 73 | $15,184 | $5,499 | 36.2% |
| 93650 | Destruction of heart conduction tissue to create heart block | Facility | 2023 | 12 | 12 | $22,812 | $5,490 | 24.1% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 59 | 77 | $19,713 | $5,341 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $11,144 | $4,813 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $11,840 | $4,371 | 36.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 34 | 195 | $16,575 | $3,717 | 22.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 35 | 39 | $15,210 | $3,304 | 21.7% |
| 93662 | Ultrasound evaluation of heart blood vessel with review by radiologist | Facility | 2023 | 53 | 54 | $46,764 | $3,209 | 6.9% |
About Dr. David Tschopp, MD
Dr. David Tschopp, MD is a Cardiovascular Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285679431.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Tschopp, MD has received a total of $150,758 in payments from pharmaceutical and medical device companies, with $7,808 received in 2024. These payments were reported across 1,499 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($50,041).
As a Medicare-enrolled provider, Tschopp has provided services to 18,100 Medicare beneficiaries, totaling 31,767 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 160 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Austin, TX
- Active Since 06/19/2006
- Last Updated 02/10/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1285679431
Products in Payments
- ELIQUIS (Drug) $27,969
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $25,533
- XARELTO (Drug) $13,734
- SYNERGY ABLATION SYSTEM (Device) $11,064
- EPI-SENSE GUIDED COAGULATION SYS (Device) $10,041
- ATRICURE ATRICLIP LAA EXCLUSION SYSTEM (Device) $8,657
- Ensite Cardiac Mapping System (Device) $5,995
- ASSURITY (Device) $5,246
- GALLANT (Device) $4,886
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $4,616
- AVEIR (Device) $4,361
- CARTO 3 (Device) $4,251
- LARIAT RS (Device) $3,121
- Assurity Pacemaker (Device) $2,570
- WATCHMAN (Device) $1,852
- Fortify Assura, Ellipse ICD (Device) $1,550
- MULTAQ (Drug) $843.06
- EnSite Precision Cardiac Mapping System (Device) $766.27
- LifeVest (Device) $722.37
- Cardiac Mapping System (Device) $662.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Austin
Dr. Andrea Natale, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M
Dr. Jason Zagrodzky, M.d, M.D
Cardiovascular Disease — Payments: $953,600
Cardiovascular Disease $953,600
Dr. Rodney Horton, M.d, M.D
Cardiovascular Disease — Payments: $720,616
Cardiovascular Disease $720,616
Francis Zidar, Md, MD
Cardiovascular Disease — Payments: $448,847
Cardiovascular Disease $448,847
Vivek Goswami, Md, MD
Cardiovascular Disease — Payments: $338,027
Cardiovascular Disease $338,027
Dr. Robert Canby, M.d, M.D
Cardiovascular Disease — Payments: $225,010
Cardiovascular Disease $225,010